Risking health to avoid injections: preferences of Canadians with type 2 diabetes.

Improved glycemic control reduces the risk of long-term diabetes complications (1–3). However, subcutaneous insulin injections represent a barrier to achieving “optimal” blood glucose levels, particularly among type 2 diabetic patients (4). Indeed, some patients even delay initiation of therapy to avoid injections (5). This study used conjoint analysis to quantify the relative importance that Canadian patients with type 2 diabetes place on short-term treatment outcomes and on the frequency of insulin injections.